Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 11, 2024
Cell
fate
and
microenvironmental
changes
resulting
from
aberrant
expression
of
specific
proteins
in
tumors
are
one
the
major
causes
inadequate
anti-tumor
immune
response
poor
prognosis
head
neck
cancer
(HNC).
Eukaryotic
initiation
factor
3C
(eIF3c)
has
emerged
as
a
promising
therapeutic
target
for
HNC
due
to
its
ability
regulate
protein
levels
tumor
cells,
but
drug
development
is
difficult
achieve
by
targeting
traditional
protein-protein
interactions.
siRNA
highly
modality
eIF3c,
while
application
hindered
challenges
pertaining
stability
insufficient
concentration
specifically
within
sites.
We
employed
method
convert
flexible
siRNAs
into
stable
biologically
active
infinite
Auric-sulfhydryl
coordination
supramolecular
(IacsRNAs).
Through
coordinated
self-assembly,
we
successfully
transformed
eIF3C
carrier-free
nanotherapeutic
agent
Iacs-eif3c-RNA.
The
efficacy
this
was
evaluated
vivo
using
xenograft
models,
demonstrating
antitumor
effects.
Iacs-eif3c-RNA
demonstrated
overcome
pharmacological
obstacle
associated
with
eIF3C,
significant
reduction
tissues,
well
effective
cell
proliferating
suppression
apoptosis
promotion.
In
comparison
monotherapy
utilizing
chemotherapeutic
cisplatin,
exhibited
superior
favorable
biosafety.
utilization
presents
innovative
approach
addressing
treating
challenges.
Moreover,
strategy
demonstrates
potential
translation
clinical
drugs,
extending
applicability
treatment
other
cancers
various
diseases.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 515 - 515
Published: Jan. 9, 2025
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
an
aggressive
cancer
with
poor
outcomes
due
to
frequent
recurrence,
metastasis,
and
resistance
treatment.
A
major
contributor
this
the
tumor's
ability
suppress
natural
killer
(NK)
cells,
which
are
key
players
in
immune
system's
fight
against
cancer.
In
PDAC,
tumor
microenvironment
(TME)
creates
conditions
that
impair
NK
cell
function,
including
reduced
proliferation,
weakened
cytotoxicity,
limited
infiltration.
This
review
examines
how
interactions
between
tumor-derived
factors,
TME
contribute
progression
treatment
resistance.
To
address
these
challenges,
we
propose
a
new
"Triple
Cell
Biomarker
Approach".
strategy
focuses
on
identifying
biomarkers
from
three
critical
areas:
characteristics,
suppression
mechanisms.
approach
could
guide
personalized
treatments
enhance
activity.
Additionally,
highlight
potential
of
combining
cell-based
therapies
conventional
repurposed
drugs
improve
for
PDAC
patients.
While
progress
has
been
made,
more
research
needed
better
understand
dysfunction
develop
effective
overcome
barriers.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4140 - 4140
Published: April 9, 2024
Despite
incessant
research,
colorectal
cancer
(CRC)
is
still
one
of
the
most
common
causes
fatality
in
both
men
and
women
worldwide.
Over
time,
advancements
medical
treatments
have
notably
enhanced
survival
rates
patients
with
cancer.
Managing
metastatic
CRC
involves
a
complex
tradeoff
between
potential
benefits
adverse
effects
treatment,
considering
factors
like
disease
progression,
treatment
toxicity,
drug
resistance,
overall
impact
on
patient's
quality
life.
An
increasing
body
evidence
highlights
significance
stem
cell
(CSC)
concept,
proposing
that
CSCs
occupy
central
role
triggering
been
focal
point
extensive
research
variety
types,
including
CRC.
Colorectal
cells
(CCSCs)
play
crucial
tumor
initiation,
metastasis,
therapy
making
them
targets.
Various
methods
exist
for
isolating
CCSCs,
understanding
mechanisms
resistance
associated
crucial.
This
paper
offers
an
overview
current
pertaining
to
comprehension
Cell Communication and Signaling,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 17, 2025
Pharmacological
targeting
of
Hedgehog
(HH)/GLI
has
proven
effective
for
certain
blood,
brain
and
skin
cancers
including
basal
cell
carcinoma
(BCC).
However,
limited
response
rates
the
development
drug
resistance
call
improved
anti-HH
therapies
that
take
synergistic
crosstalk
mechanisms
immune
evasion
strategies
into
account.
In
previous
work,
we
demonstrated
cooperation
HH/GLI
Interleukin
6
(IL6)/STAT3
signaling
drives
BCC
growth.
Whether
HH-IL6
promotes
via
activation
remained
unclear.
regulated
immunosuppressive
genes
such
as
indoleamine
2,3-dioxygenase
1
(IDO1)
were
identified
by
gene
expression
profiling.
IDO1
was
evaluated
in
human
melanoma
models
qPCR
Western
blot
analyses.
The
cis-regulatory
region
interrogated
HH-IL6-regulated
GLI
STAT
transcription
factor
binding
epigenetic
modifications
targeted
chromatin-immunoprecipitation
bisulfite
pyrosequencing.
Functional
analyses
effects
involved
HPLC-MS
measurements
its
metabolites
assessment
T
proliferation
flow
cytometry.
Bioinformatic
GLI-STAT
conducted
on
published
bulk
single-cell
RNA-seq
data
patients.
We
a
target
cooperative
activity
melanoma.
GLI1
STAT3
factors
synergistically
enhanced
jointly
to
increasing
active
chromatin
marks
at
histone
level.
cells,
inhibition
prevented
induction
IL6/STAT3
IFNγ/STAT1
signaling.
reduced
expression,
resulting
decreased
production
metabolite
kynurenine.
Further,
efficacy
selective
inhibitor
epacadostat
rescued
attenuating
IDO1/kynurenine-mediated
immunosuppression.
Elevated
correlated
with
JAK/STAT
cancer
patients
supporting
clinical
relevance
mechanistic
presented.
These
results
identify
IDO1-kynurenine
pathway
novel
pro-tumorigenic
oncogenic
STAT1/STAT3
cooperation.
Our
suggest
simultaneous
pharmacological
these
axes
rational
combination
therapy
non-melanoma
cancers.
Cells,
Journal Year:
2025,
Volume and Issue:
14(7), P. 538 - 538
Published: April 3, 2025
Stem
cells
have
emerged
as
a
pivotal
area
of
research
in
the
field
oncology,
offering
new
insights
into
mechanisms
cancer
initiation,
progression,
and
resistance
to
therapy.
This
review
provides
comprehensive
overview
role
stem
cancer,
focusing
on
(CSCs),
their
characteristics,
implications
for
We
discuss
origin
identification
CSCs,
tumorigenesis,
metastasis,
drug
resistance,
potential
therapeutic
strategies
targeting
CSCs.
Additionally,
we
explore
use
normal
therapy,
tissue
regeneration
delivery
vehicles
anticancer
agents.
Finally,
highlight
challenges
future
directions
cell
cancer.
Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
195, P. 106858 - 106858
Published: July 19, 2023
Aberrant
activation
of
Hedgehog
(HH)
signaling
in
cancer
is
the
result
genetic
alterations
upstream
pathway
components
(canonical)
or
other
oncogenic
mechanisms
(noncanonical),
that
ultimately
concur
to
activate
zinc-finger
transcription
factors
GLI1
and
GLI2.
Therefore,
inhibition
GLI
activity
a
good
therapeutic
option
suppress
both
canonical
noncanonical
HH
pathway.
However,
only
few
inhibitors
are
available,
none
them
have
profile
required
for
clinical
development
due
poor
metabolic
stability
aqueous
solubility,
high
hydrophobicity.
Two
promising
quinoline
were
selected
by
virtual
screening
subjected
hit-to-lead
optimization,
thus
leading
identification
4-methoxy-8-hydroxyquinoline
derivative
JC19.
This
molecule
impaired
GLI2
activities
several
cellular
models
interfering
with
binding
DNA.
JC19
suppressed
cell
proliferation
enhancing
apoptosis,
inducing
strong
anti-tumor
response
lines
vitro.
Specificity
towards
was
demonstrated
lower
GLI1-
GLI2-depleted
cells.
showed
excellent
passive
permeability.
Notably,
inhibited
GLI1-dependent
melanoma
xenograft
growth
vivo,
no
evidence
toxic
effects
mice.
These
results
highlight
potential
as
novel
anti-cancer
agent
targeting
Cellular and Molecular Life Sciences,
Journal Year:
2025,
Volume and Issue:
82(1)
Published: Jan. 21, 2025
Prolonged
spaceflight
is
known
to
cause
vascular
deconditioning
and
remodeling.
Tail
suspension,
a
widely
used
analog,
reported
result
in
remodeling
of
rats.
However,
little
about
the
cellular
atlas
heterogeneous
cells
CA
FA
from
hindlimb-unloaded
Firstly,
we
leveraged
scRNA-seq
perform
clustering
analysis
identify
diverse
cell
populations
sub-clusters
within
rats
subjected
3
months
hindlimb
unloading.
The
dysregulated
genes
specific
for
artery
types
HU
group
compared
Con
were
unraveled.
Then
R
package
"Cellchat"
was
reveal
ligand-receptor
communication.
At
last,
TF
network
performed
using
SCENIC
predict
pivotal
TFs
rat
induced
by
Clustering
identified
ECs,
SMCs,
fibroblasts,
spectrum
immune
cells,
as
well
neuronal
stem
cells.
Notably,
an
increased
percentage
ECs
diminished
proportion
SMCs
both
observed
following
tail
suspension.
Intersection
type
after
suspension
revealed
several
gene
sets
involved
ECM
remodeling,
inflammation,
vasoconstriction,
etc.
Fibroblasts,
particular,
exhibited
most
significant
expression
variability,
highlighting
their
plasticity.
Subclustering
fibroblasts
specialized
subsets
engaged
processes
such
EndoMT
cycle
checkpoint
regulation.
Additionally,
enhanced
intercellular
interactions
among
major
types,
especially
between
SMC
fibroblast,
underscored
importance
communication
Several
potentially
influential
process
under
simulated
microgravity
conditions.
This
study
presents
first
conductive
arteries
rats,
revealing
profiles.
identification
subclusters
transcription
factors
prediction
are
also
included
this
work.
findings
provide
reference
future
research
on
long-duration
spaceflight.
Open Life Sciences,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: Jan. 1, 2025
Abstract
Hepatocellular
carcinoma
(HCC)
is
a
cancer
with
poor
prognosis,
underscoring
the
urgent
need
for
enhanced
detection
and
management.
This
study
aimed
to
investigate
role
of
Collectin
Subfamily
Member
10
(COLEC10)
in
HCC,
which
was
revealed
be
associated
various
diseases.
Bioinformatics
tools,
including
GEO,
cBioPortal,
TCGA,
were
used
identify
differentially
expressed
genes.
The
prognostic
significance
COLEC10
assessed
two
patient
cohorts,
its
functional
impact
on
Hep3B
SMMC7721
cells
evaluated
through
CCK-8
Transwell
assays.
underlying
mechanisms
HCC
progression
explored
using
flow
cytometry
western
blot.
downregulated
poorer
overall
survival
disease
progression.
potential
interaction
COLEC10,
CCBE1,
FCN3
predicted.
identified
as
indicators
HCC.
Overexpression
inhibited
proliferation,
migration,
invasion
cells.
overexpression
induced
G0/G1
cell
cycle
arrest
suppressed
epithelial–mesenchymal
transition
(EMT),
regulated
protein
expression
Hedgehog
pathway
phosphorylation
key
proteins
PI3K-AKT
pathway.
an
independent
factor
regulates
EMT,
Hedgehog,
pathways,
providing
new
ideas
targeted
therapy